Highlights KYORIN Pharmaceutical Co., Ltd.

Equities

4569

JP3247090008

Market Closed - Japan Exchange Other stock markets 07:00:00 17/05/2024 BST			5-day change	1st Jan Change
1,712 ^JPY	+0.12%		-6.40%	-3.82%

2023	ATyr Pharma to Obtain $10 Million in Milestone Payment After Partner Starts Dosing Patients in Lung Disease Study in Japan	MT
2021	KYORIN Holdings, Inc.(TSE:4569) dropped from S&P Japan 500	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Final dividend	03-27	FA
Ex-dividend day for interim dividend	27/09/23	FA
Ex-dividend day for final dividend	29/03/23	FA
Ex-dividend day for interim dividend	28/09/22	FA
Ex-dividend day for final dividend	29/03/22	FA
Ex-dividend day for interim dividend	28/09/21	FA
Ex-dividend day for final dividend	29/03/21	FA
Ex-dividend day for interim dividend	28/09/20	FA
Ex-dividend day for final dividend	29/03/20	FA
KYORIN Holdings, Inc. Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2019; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2020	04/02/20	CI
KYORIN Holdings, Inc. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2019; Provides Consolidated Earnings Guidance for the Fiscal Year 2020 Ending March 31, 2020; Announces Dividend for the Second Quarter Ended September 30, 2019, Payable on December 3, 2019; Provides Dividend Forecast for the Fiscal Year Ending March 31, 2020	06/11/19	CI
Ex-dividend day for interim dividend	26/09/19	FA
KYORIN Holdings, Inc. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2019; Provides Consolidated Earnings Guidance for the First Half of Fiscal Year 2020 and Year Ending March 31, 2020	30/07/19	CI
Ex-dividend day for final dividend	26/03/19	FA
Tranche Update on KYORIN Holdings, Inc.'s Equity Buyback Plan announced on September 26, 2018.	27/09/18	CI
KYORIN Holdings, Inc.'s Equity Buyback announced on September 26, 2018 has expired with 16,574,000 shares for ¥40,838.34 million. The company repurchased 14,328,000 shares, representing 19.18% of the outstanding shares, for ¥35,300 million from Teijin Limited.	26/09/18	CI
KYORIN Holdings, Inc. announces an Equity Buyback for 18,000,000 shares, representing 24.09% for ¥44,352 million.	26/09/18	CI
KYORIN Holdings, Inc. authorizes a Buyback Plan.	25/09/18	CI
Ex-dividend day for interim dividend	25/09/18	FA
KYORIN Holdings, Inc. Announces Consolidated Earnings Results for the Full Year Ended March 31, 2018; Provides Earnings for the First Half and Full Year of Fiscal Year Ending March 31, 2019	09/05/18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights KYORIN Pharmaceutical Co., Ltd.

Equities

4569

JP3247090008

Highlights

Filters